The federal multidistrict litigation (MDL) over Ozempic and other GLP-1 drugs continues to expand, now encompassing claims related to Saxenda but remaining focused on gastrointestinal injuries like gastroparesis, small bowel obstruction, and gallbladder issues
In todays fast-moving pharmaceutical market, the demand for high-quality neurological supplements is growing rapidly
The United Arab Emirates is the Middle East's most active startup hub, with tens of thousands of companies clustered in Dubai and Abu Dhabi
Baseline serum B12, folate, homocysteine, methylmalonic acid, and liver function tests (ALT, AST) inform starting status and response potential
The rarity of the lesion, which may present at different localizations create difficulty in placing a correct initial diagnosis
Some pretty big words, right